Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.
Saved in:
| Title: | Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. |
|---|---|
| Authors: | Nitta, Kyoko1, Shi, Sen1,2, Nagai, Takako1, Kanasaki, Megumi1, Kitada, Munehiro1,2, Srivastava, Swayam Prakash1, Haneda, Masakazu3, Kanasaki, Keizo1,2, Koya, Daisuke1,2 |
| Source: | BioMed Research International. 3/20/2016, Vol. 2016, p1-11. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 23146133 |
|---|---|
| DOI: | 10.1155/2016/9172157 |
